Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
CH0038389992
Fri, 25.10.2024
BB BIOTECH AG
Media release as at October 25, 2024
Portfolio of BB Biotech AG as at September 30, 2024
BB Biotech: Strategic reallocation of portfolio assets progressing
In the third quarter of 2024, stock markets remained volatile. The recent rate cut by the US central bank has improved the market dynamics for the biotechnology sector because lower interest [ … ]
Wed, 23.10.2024
Edison Investment Research Limited
London, UK, 23 October 2024
Edison issues report on BB Biotech (BION)
Edison issues report on BB Biotech (BION).
BB Biotech (BION) invests in innovative, rapidly expanding biotech companies. BION’s portfolio company Wave Life Sciences (Wave) recently announced a significant milestone in the field of genetic medicine: the first successful t [ … ]
Fri, 26.07.2024
BB BIOTECH AG
Media release as at July 26, 2024
Portfolio of BB Biotech AG as at June 30, 2024
Substantial pipeline progress at several portfolio companies offsets rate-related market volatility
Global equity indices climbed to new record highs during the second quarter, driven by just a few mega tech stocks, but investors continued to shun the healthcare sec [ … ]
Wed, 26.06.2024
Edison Investment Research Limited
London, UK, 26 Juni 2024
Edison issues report on BB Biotech (BION)
Click here to view the full report.
All reports published by Edison are available to download free of charge from its website
www.edisongroup.com
Edison is authorised and regulated by the Financial Conduct Authority.
Edison is not an adviser or broker-dealer and does not [ … ]
Mon, 20.05.2024
Edison Investment Research Limited
London, UK, 20 May 2024
Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis
BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its investment company peers, focused on high-quality biotech assets that target substantial [ … ]
Fri, 26.04.2024
BB BIOTECH AG
Media release as at April 26, 2024
Portfolio of BB Biotech AG as at March 31, 2024
BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
Investor sentiment in the biotech space continues to be shaped by the general interest rate environment. Biotechnology stocks traded higher early in [ … ]
Thu, 21.03.2024
BB BIOTECH AG
Media release of March 21, 2024
Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
All proposals of BB Biotech AG's Board of Directors were approved by BB Biotech AG's shareholders at its Annual General Meeting held today.
Shareholders voted in favor of the proposal to pay out a divi [ … ]
Wed, 14.02.2024
BB BIOTECH AG
Release as at February 14, 2024Investor interest returns – dividend yield remains high for 2024
After a difficult 2023 stock market year, above all due to higher interest rates, the capital markets are now once again looking at biotech companies with interest. The prospect of falling interest rates has led to a rethink. While the majority of inves [ … ]
Fri, 19.01.2024
BB BIOTECH AG
Media release as at January 19, 2024
Portfolio of BB Biotech AG as at December 31, 2023
End of year biotech equity market rally – M&A and end of rate hike cycle
In 2023, global equity performed better than anticipated by many. The US central bank moderated and then paused interest rate hikes. These developments resulted in a year-end bond ma [ … ]